A metabolomic signature of the APOE2 allele-Reference-Cited by-同舟云学术

A metabolomic signature of the APOE2 allele

Published:2022-08-23 Issue:1 Volume:45 Page:415-426
ISSN:2509-2715
Container-title:GeroScience
language:en
Short-container-title:GeroScience

Author:

Sebastiani Paola^ORCID,Song Zeyuan,Ellis Dylan,Tian Qu,Schwaiger-Haber Michaela,Stancliffe Ethan,Lustgarten Michael S.,Funk Cory C.,Baloni Priyanka,Yao Cong-Hui,Joshi Shakchhi,Marron Megan M.,Gurinovich Anastasia,Li Mengze,Leshchyk Anastasia,Xiang Qingyan,Andersen Stacy L.,Feitosa Mary F.,Ukraintseva Svetlana,Soerensen Mette,Fiehn Oliver,Ordovas Jose M.,Haigis Marcia,Monti Stefano,Barzilai Nir,Milman Sofiya,Ferrucci Luigi,Rappaport Noa,Patti Gary J.,Perls Thomas T.

Funder

NIH

Office of Research on Women's Health

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology,Aging

Link

https://link.springer.com/content/pdf/10.1007/s11357-022-00646-9.pdf

Reference53 articles.

1. Ji Y, et al. Apolipoprotein Epsilon epsilon4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord. 2013;36(3–4):163–70.

2. Farrer LA, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis APOE and Alzheimer Disease Meta Analysis Consortium. Jama. 1997;278(16):1349–56.